Latest Platform Integration News

Rewardle Holdings has cleared a major compliance hurdle by releasing its preliminary report, spotlighting its strategic investment in cardiac MedTech firm CloudHolter and ongoing B2B2C platform development.

OpenLearning Limited reported a 30% revenue increase for the half-year to June 2025, driven by expanded AI-powered LMS adoption and multi-year contracts in the Philippines, while working towards break-even despite a wider loss.

Beonic Ltd reported a significantly reduced net loss of $3.17 million for FY2025, alongside improved margins and EBITDA profitability, underpinned by a major North African airport contract and a $4.18 million convertible note raise to accelerate growth.

Prophecy International Holdings reported a 5% revenue decline and a 53% increase in net loss for FY25, while advancing key product developments and announcing a transformative merger with Complexica.

Algorae Pharmaceuticals reported a 62% reduction in net loss for FY2025, driven by R&D tax credits and cost efficiencies, while making significant strides in its AI drug discovery platform and therapeutic candidates.

Camplify Holdings Limited reported a 12.3% revenue decline to $42.1 million and a near doubling of net loss to $15.8 million in FY25, reflecting a year of strategic transformation including the launch of its MyWay protection product and completion of European platform integration.

BetMakers Technology Group delivered a strong FY25 with a 5.6% half-on-half revenue growth and record profitability, while advancing its technology transformation and signing a strategic acquisition in Nevada.

AI-Media Technologies has accelerated its transformation into a technology-led business, reporting a 19% increase in technology revenue and launching its AI-powered LEXI Voice product in FY25.

Asset Vision Co Limited reported a 22.9% increase in revenue to $5.03 million for FY2025, alongside a widening net loss of $385,797. The company’s Annual Recurring Revenue surged 28%, supported by new contracts and product innovation.

Decidr AI Industries has agreed to acquire the remaining 49% stake in Decidr.ai, issuing 78.4 million shares to complete full ownership and accelerate its AI platform integration.

hipages Group reported a 10% revenue increase for FY25, driven by strong SaaS platform adoption and operational efficiencies, despite a 33% net profit decline influenced by prior year gains.

Artrya Limited has secured FDA 510(k) clearance for its Salix Coronary Plaque module, enabling near real-time detection of high-risk coronary artery plaque and opening a lucrative U.S. market opportunity with a $950 reimbursement per scan.